News

Merck spends $10 billion for Verona, gaining access to its COPD medication
The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.
The Marion Star on MSN7h
Community members sweep streets, raise brooms in memory of friend to all, Kenny Spafford
Kenneth "Kenny" M. Spafford was remember fondly by community members as then lined the street in his memory on Wednesday, ...
Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch
Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.
Dave Flebotte, ‘Desperate Housewives’ and ‘Tulsa King’ Writer-Producer, Dies at 65
The Emmy nominee also created Sherri Shepherd's sitcom and worked on 'Ellen,' 'The PJs,' 'Boardwalk Empire' and more.
Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue
Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...
BioPharma Dive11h
Merck to buy Verona and its lung drug in $10B deal
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
Two big reasons why buying Verona was crucial for Merck
Verona Pharma Plc (NASDAQ: VRNA) rallied about 20% on Wednesday after Merck & Co Inc (NYSE: MRK) said it will buy the ...
The American Journal of Managed Care15h
Future Directions: Addressing Persistent Challenges in Fibrosis Care
Panelists discuss that improving outcomes for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) requires multifaceted efforts including developing ...